Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$3.69B |
| 2 |
Abbott
ABT
|
+$3.65B |
| 3 |
Qualcomm
QCOM
|
+$3.54B |
| 4 |
Procter & Gamble
PG
|
+$3.42B |
| 5 |
Accenture
ACN
|
+$3.28B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$2.86B |
| 2 |
AbbVie
ABBV
|
+$2.71B |
| 3 |
Valero Energy
VLO
|
+$1.86B |
| 4 |
Lockheed Martin
LMT
|
+$916M |
| 5 |
Halliburton
HAL
|
+$856M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 10.68% |
| 3 | Healthcare | 10.19% |
| 4 | Industrials | 8.63% |
| 5 | Consumer Discretionary | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Ocular Therapeutix
OCUL
$1.87B
| $12.4M | ﹤0.01% |
1,461,177
+720
| +0% | +$6.86K |
|
2002
F&G Annuities & Life
FG
$3.93B
| $12.4M | ﹤0.01% |
488,775
+60,051
| +14% | +$1.57M |
|
2003
Wabash National
WNC
$527M
| $12.3M | ﹤0.01% |
1,429,986
-118,507
| -8% | -$1.18M |
|
2004
Tandem Diabetes Care
TNDM
$1.14B
| $12.3M | ﹤0.01% |
642,598
-3,712
| -0.6% | -$80.7K |
|
|
BRSL
2005
Brightstar Lottery PLC
BRSL
$1.94B
| $12.3M | ﹤0.01% |
965,633
-194,263
| -17% | -$2.68M |
|
2006
Nomad Foods
NOMD
$1.67B
| $12.3M | ﹤0.01% |
1,279,588
+34,853
| +3% | +$400K |
|
2007
AtriCure
ATRC
$1.87B
| $12.3M | ﹤0.01% |
429,833
-8,050
| -2% | -$275K |
|
|
RWT
2008
Redwood Trust
RWT
$620M
| $12.2M | ﹤0.01% |
2,176,668
+6,676
| +0.3% | +$38.7K |
|
2009
Howard Hughes
HHH
$3.97B
| $12.2M | ﹤0.01% |
192,782
+5,327
| +3% | +$399K |
|
2010
Shenandoah Telecom
SHEN
$631M
| $12.1M | ﹤0.01% |
787,497
-8,579
| -1% | -$112K |
|
2011
Southside Bancshares
SBSI
$967M
| $12.1M | ﹤0.01% |
389,867
-16,010
| -4% | -$507K |
|
2012
Nektar Therapeutics
NKTR
$2.38B
| $12.1M | ﹤0.01% |
168,007
+47,627
| +40% | +$2.71M |
|
2013
Intellia Therapeutics
NTLA
$1.51B
| $12.1M | ﹤0.01% |
941,285
-4,471
| -0.5% | -$57K |
|
2014
Mineralys Therapeutics
MLYS
$2.45B
| $12M | ﹤0.01% |
443,898
-17,402
| -4% | -$510K |
|
|
ADAM
2015
Adamas Trust
ADAM
$790M
| $12M | ﹤0.01% |
1,633,004
-153,219
| -9% | -$1.22M |
|
2016
Designer Brands
DBI
$294M
| $12M | ﹤0.01% |
2,109,030
-76,795
| -4% | -$516K |
|
2017
Clear Channel Outdoor Holdings
CCO
$1.23B
| $12M | ﹤0.01% |
5,060,149
-329,481
| -6% | -$746K |
|
|
OS
2018
DELISTED
OneStream Inc
OS
| $12M | ﹤0.01% |
499,512
+27,948
| +6% | +$655K |
|
2019
Colliers International
CIGI
$5.19B
| $12M | ﹤0.01% |
112,393
+1,630
| +1% | +$203K |
|
2020
NextNav
NN
$1.7B
| $11.9M | ﹤0.01% |
745,006
-10,695
| -1% | -$173K |
|
2021
Barclays
BCS
$95B
| $11.9M | ﹤0.01% |
563,103
+22,138
| +4% | +$540K |
|
2022
Bausch Health
BHC
$1.7B
| $11.9M | ﹤0.01% |
2,209,567
+163,830
| +8% | +$980K |
|
|
JKS
2023
JinkoSolar
JKS
$793M
| $11.8M | ﹤0.01% |
465,227
+50,999
| +12% | +$1.35M |
|
2024
AB InBev
BUD
$156B
| $11.8M | ﹤0.01% |
169,906
+32,045
| +23% | +$2.31M |
|
|
TIC
2025
TIC Solutions Inc
TIC
$1.59B
| $11.8M | ﹤0.01% |
1,787,909
+231,532
| +15% | +$2.18M |
|
Similar funds
Charles Schwab's Q1 2026 Portfolio in Review
As of Q1 2026, Charles Schwab held 3,535 positions worth $654B, up 1.7% from $644B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Charles Schwab deployed $21.4B of net new capital in Q1 2026, opening 79 new positions and adding to 1,903 existing holdings. Its largest new stake was JPMorgan Income ETF: 8,679,689 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Cisco, an estimated $2.86B trimmed.
- Charles Schwab's largest Q1 2026 buy was JPMorgan Income ETF: 8,679,689 shares worth $400M.
- Charles Schwab added most to UnitedHealth in Q1 2026, an estimated $3.69B increase.
- Charles Schwab's biggest Q1 2026 reduction was Cisco, cutting an estimated $2.86B.
- Charles Schwab fully exited Comerica in Q1 2026, selling an estimated $412M.
- Charles Schwab's ten largest holdings make up 22% of its $654B portfolio in Q1 2026.
- Charles Schwab opened 79 new positions and closed 80 in Q1 2026.
- Charles Schwab's portfolio value rose 1.7% quarter-over-quarter to $654B.
Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.